当前位置: X-MOL 学术Obesity › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Societal Value of Broader Access to Antiobesity Medications.
Obesity ( IF 4.2 ) Pub Date : 2019-12-23 , DOI: 10.1002/oby.22696
Mina Kabiri 1 , Alison Sexton Ward 1 , Abhilasha Ramasamy 2 , Emma van Eijndhoven 1 , Rahul Ganguly 2 , B Gabriel Smolarz 2 , Tracy Zvenyach 2 , Dana P Goldman 1 , James R Baumgardner 1
Affiliation  

Obesity and its complications place an enormous burden on society. Yet antiobesity medications (AOM) are prescribed to only 2% of the eligible population, even though few individuals can sustain weight loss using other strategies alone. This study estimated the societal value of greater access to AOM.

中文翻译:

广泛获得抗肥胖药的社会价值。

肥胖及其并发症给社会带来了巨大的负担。然而,即使只有很少的人能够单独使用其他策略来维持减肥,但仅对2%的合格人群开出了抗肥胖药(AOM)。这项研究估计了更多使用AOM的社会价值。
更新日期:2019-12-23
down
wechat
bug